Monarch Capital Management’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

Monarch Capital Management’s Portfolio ENZN Stock Details ENZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-10,000	Closed	-$4K	–	101
2016 Q3	$4K	Hold	10,000	–	–	﹤0.01%	100
2016 Q2	$4K	Hold	10,000	–	–	﹤0.01%	99
2016 Q1	$5K	Hold	10,000	–	–	﹤0.01%	100
2015 Q4	$7K	Hold	10,000	–	–	﹤0.01%	98
2015 Q3	$10K	Hold	10,000	–	–	﹤0.01%	98
2015 Q2	$12K	Hold	10,000	–	–	﹤0.01%	101
2015 Q1	$11K	Hold	10,000	–	–	﹤0.01%	106
2014 Q4	$11K	Hold	10,000	–	–	﹤0.01%	100
2014 Q3	$11K	Buy	+10,000	New	+$12.3K	﹤0.01%	98

Other funds holding ENZN

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

CFA

CT Financial Advisors Chadds Ford, Pennsylvania $162M AUM 9.58% 1-Year Est. Return

Monarch Capital Management's ENZN Position: Q4 2016 in Review

Monarch Capital Management sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q4 2016, closing a stake of 10,000 shares — an estimated $4K sold.

Monarch Capital Management first reported a position in ENZN in Q3 2014 and held it in 9 quarters. The position peaked at $12K in Q2 2015. 2 funds tracked by Wall St. Rank hold ENZN as of Q4 2016.

Monarch Capital Management reported no remaining ENZON PHARMACEUTICALS INC position as of Q4 2016 after selling out during the quarter.
Monarch Capital Management sold 10,000 ENZON PHARMACEUTICALS INC shares in Q4 2016, an estimated $4K.
Monarch Capital Management first reported a position in ENZON PHARMACEUTICALS INC in Q3 2014 and held it in 9 quarters.
Monarch Capital Management's ENZON PHARMACEUTICALS INC position peaked at $12K in Q2 2015.
2 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q4 2016.

Based on Monarch Capital Management's 13F filing for Q4 2016, filed 24 Jan 2017.